APD421

DRUG7 trials

Sponsors

Acacia Pharma Ltd

Conditions

Chemotherapy-induced Nausea and VomitingPONVPostoperative Nausea and Vomiting

Phase 1

Study of APD421 With and Without Ondansetron

CompletedNCT03583489

Acacia Pharma LtdPostoperative Nausea and Vomiting

Start: 2018-07-17End: 2018-08-13Updated: 2018-10-01

Phase 2

Phase II Proof-of-concept Study of APD421

CompletedNCT01303978

Acacia Pharma LtdChemotherapy-induced Nausea and Vomiting

Start: 2011-02-28End: 2012-07-31Updated: 2012-09-25

Phase II Dose-ranging Study of APD421 in PONV

CompletedNCT01510704

Acacia Pharma LtdPostoperative Nausea and Vomiting

Start: 2012-01-31End: 2012-04-30Updated: 2019-03-05

Phase 3

European Phase III Study of APD421 in PONV

CompletedNCT01991821

Acacia Pharma LtdPONV

Start: 2013-07-31End: 2014-01-31Updated: 2019-08-20

Phase IIIb Study of APD421 in Combination as PONV Prophylaxis

CompletedNCT02337062

Acacia Pharma LtdPONV

Start: 2015-02-28End: 2015-09-30Updated: 2019-03-20

Study of APD421 as PONV Treatment (no Prior Prophylaxis)

CompletedNCT02449291

Acacia Pharma LtdPostoperative Nausea and Vomiting

Start: 2015-09-30End: 2016-07-31Updated: 2019-01-22

Study of APD421 as PONV Treatment (Prior Prophylaxis)

CompletedNCT02646566

Acacia Pharma LtdPostoperative Nausea and Vomiting

Start: 2016-03-31End: 2017-01-31Updated: 2019-01-22